Iridex (IRIX) 2026 Earnings: Q1 Review & Outlook Guide
A clear, investor-friendly look at Iridex's Q1 2026 performance and what it could mean for the full year. Learn the n...
Knowing where to keep your cash savings securely is essential for peace of mind. Explore the safest options available to you.
22,893 articlesA clear, investor-friendly look at Iridex's Q1 2026 performance and what it could mean for the full year. Learn the n...
In a world of fast trades and flashy headlines, legendary investor chuck akre quietly looks for durable businesses, c...
Tilray shifted from cannabis focus to a BrewDog partnership in search of diversification. But early UK sales data rai...
June presents a pivotal moment for growth stocks tied to travel. Here are three practical reasons airbnb growth stock...
AbbVie is exploring a cash purchase of about $10.9 billion for a biotech developing an experimental eczema drug, a mo...
A fresh market screen identifies five high-yield dividend stocks trading under $10, presenting a potential income lif...
As biotech investors look to 2026, crispr therapeutics viking therapeutics presents two distinct paths: gene editing ...
Investors explore funding a beachfront home through dividend income. This article outlines realistic yields, annual c...
A single quarterly filing can rewrite a fund’s star players. Tepper’s Appaloosa appears to have shifted away from NVI...
IonQ posted quarterly results that beat expectations, triggering a notable after-hours rally. Analysts warn the stock...
SoundHound AI is delivering impressive revenue momentum, but its stock has tumbled. This analysis breaks down the dri...
In a turbulent 2026 market, CVS Health and Cigna are at the center of retirement portfolio debates. This piece weighs...